S216: CD47/PD-L1 BISPECIFIC ANTIBODY (IBI322) IN ANTI-PD-1 OR PD-L1 TREATMENT-RESISTANT CLASSICAL HODGKIN LYMPHOMA: A PHASE I STUDY

ABSTRACT:

SUBMITTER: Zhang H 

PROVIDER: S-EPMC10428475 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature